Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) — The “Vaccine Logistics – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for Vaccine Logistics was valued at US$3.0 Billion in 2024 and is projected to reach US$3.8 Billion by 2030, growing at a CAGR of 4.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Vaccine logistics occupies a distinct niche within the cold chain logistics industry, demanding ultra-reliable temperature control, time-sensitive distribution, and regulatory-compliant traceability across geographies. Unlike general pharmaceuticals or perishables, vaccines are biologics with narrow thermal thresholds-often between 2C and 8C-and in some cases (like mRNA vaccines) requiring deep-frozen transport at -70C. These conditions must be maintained continuously through first-mile manufacturing, mid-mile air/sea transport, and last-mile delivery to clinics or immunization centers. Even minor temperature excursions can render vaccines unusable, resulting in health risks, regulatory non-compliance, and financial losses.
COVID-19 vaccine deployment revealed the scale and complexity of vaccine logistics, driving investments in ultra-low temperature freezers, IoT-enabled thermal packaging, and visibility software. Beyond pandemics, routine immunization programs managed by governments, UNICEF, and Gavi require annual delivery of billions of doses to remote and underserved locations. This necessitates specialized packaging (phase-change materials, vacuum insulation panels), passive cooling boxes, and multi-modal coordination. Challenges also include managing reverse logistics for unused or expired doses, ensuring customs clearance efficiency, and coordinating between national immunization programs and global health agencies.
What Forces Are Powering the Global Vaccine Logistics Market Forward?
The growth in the vaccine logistics market is driven by several factors, including expanded global immunization programs, rising demand for temperature-sensitive biologics, and increasing public and private investment in cold chain infrastructure. COVID-19 created a paradigm shift, exposing vulnerabilities in global vaccine distribution and catalyzing efforts to build more resilient, agile, and traceable logistics systems. National governments are now incorporating cold chain logistics planning into pandemic preparedness strategies and public health budgets, ensuring long-term demand stability.
Pharmaceutical innovation is another driver. With the growth of mRNA platforms, vector-based vaccines, and novel adjuvanted formulations, the temperature and handling requirements of vaccines are becoming more complex. This is stimulating demand for advanced packaging, passive cooling systems, and active reefer technologies across land, air, and sea modes. Moreover, international regulatory tightening-from WHO prequalification to national Good Distribution Practices (GDP)-is pushing logistics providers to enhance quality assurance, documentation, and risk management practices.
Private equity and venture capital investment in pharmaceutical logistics startups, along with global logistics majors expanding cold chain capacity (e.g., DHL, UPS, Kuehne+Nagel), further reflect growing market interest. As climate change, global health threats, and demand for equitable vaccine access reshape the global health landscape, the vaccine logistics market will remain central to delivering immunization outcomes at scale-across urban centers, rural outposts, and everything in between.
Which Technologies Are Reshaping the Future of Vaccine Transport and Storage?
Vaccine logistics is being transformed by digital supply chain platforms, real-time condition monitoring, and AI-assisted route planning. Connected sensor technologies embedded in vaccine packaging or transport containers monitor temperature, humidity, vibration, and light exposure in real time. These sensors transmit data via Bluetooth or cellular networks to cloud-based dashboards, enabling proactive risk mitigation. Pharmaceutical logistics providers now use AI algorithms to predict bottlenecks, optimize delivery windows, and reroute shipments based on weather or geopolitical disruptions.
Another innovation is the use of drone logistics and electric vehicles (EVs) for last-mile delivery in remote or urban-congested areas. Solar-powered cold boxes and portable vaccine refrigerators are also being deployed in off-grid regions. Data analytics is improving forecasting and inventory planning, reducing both stockouts and vaccine wastage. Blockchain pilots are being explored for tamper-proof tracking of vaccine provenance, batch records, and regulatory audit trails. These digital layers are essential to building trust, especially in international vaccine trade, where regulatory harmonization is often lacking.
Where Is the Demand for Specialized Vaccine Logistics Growing Most Rapidly?
Demand for specialized vaccine logistics is surging across both developed and emerging markets, driven by expanded immunization schedules, adult vaccine uptake, and epidemic preparedness initiatives. In high-income countries, the focus is on building resilient cold chains for seasonal influenza, RSV, shingles, and COVID-19 boosters. These regions are also investing in smart warehousing, temperature-controlled distribution hubs, and API integrations between vaccine manufacturers, distributors, and public health systems.
In low- and middle-income countries (LMICs), the emphasis is on last-mile access, cold chain electrification, and strengthening of public-private logistics partnerships. Global health initiatives-such as COVAX, Gavi’s Cold Chain Equipment Optimization Platform (CCEOP), and PATH’s NextGen cold chain solutions-are driving deployment of solar refrigerators, digital VVMs (vaccine vial monitors), and training for health workers. Countries in Sub-Saharan Africa, Southeast Asia, and Latin America are also adopting national vaccine logistics management systems (vLMIS) to track doses, manage inventories, and plan replenishments. Additionally, domestic vaccine manufacturing growth in India, China, and Brazil is increasing the need for intra-national cold chain capacity and compliance systems.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as 3PL – Agility, AIT Worldwide Logistics, AIT Worldwide Logistics, AllCargo Logistics, American Airlines Cargo and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Transportation Service segment, which is expected to reach US$2.2 Billion by 2030 with a CAGR of a 3.8%. The Warehousing Service segment is also set to grow at 4.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $826.7 Million in 2024, and China, forecasted to grow at an impressive 7.3% CAGR to reach $778.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Scope of the Report
- Segments: Service (Transportation Service, Warehousing Service, Value-Added Services); End-User (Hospitals End-User, Drug Manufacturers & Distributors End-User, Other End-Users).
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 269 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $3 Billion |
| Forecasted Market Value (USD) by 2030 | $3.8 Billion |
| Compound Annual Growth Rate | 4.0% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Vaccine Logistics – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
MARKET TRENDS & DRIVERS
- Global Vaccination Campaigns Throw the Spotlight on Scalable and Resilient Vaccine Logistics Infrastructure
- Expansion of Cold Chain Networks Spurs Growth in Temperature-Controlled Storage and Transportation Solutions
- Rising Demand for Last-Mile Delivery Efficiency Expands Addressable Market for Specialized Vaccine Distribution Services
- Innovation in Temperature Monitoring and IoT Integration Strengthens the Business Case for Smart Vaccine Logistics
- Increasing Use of mRNA and Biologic Vaccines Drives Adoption of Ultra-Cold Chain Logistics Technologies
- Emerging Markets Push for Immunization Equity Fuels Investment in Rural and Remote Area Distribution Capabilities
- Integration with National Immunization Programs Enhances Demand Forecasting and Inventory Management Systems
- Growth in Outsourcing by Pharma Companies Supports Expansion of Specialized Vaccine Logistics Providers
- Standardization of Packaging, Labeling, and Handling Protocols Improves Cross-Border Vaccine Movement
- Real-Time Visibility and Exception Management Tools Improve Cold Chain Integrity and Risk Mitigation
FOCUS ON SELECT PLAYERS:Some of the 32 companies featured in this Vaccine Logistics market report
- 3PL – Agility
- AIT Worldwide Logistics
- AllCargo Logistics
- American Airlines Cargo
- Americold Logistics
- Biocair
- CEVA Logistics
- Cold Chain Technologies
- DB Schenker
- DHL Global Forwarding
- DP World
- DPD/Deutsche Post AG
- Dulas Ltd.
- FedEx Corporation
- Gebruder Weiss
- IndoSurgicals Pvt. Ltd.
- Kuehne+Nagel
- LifeConEx (DHL subsidiary)
- Nippon Express
For more information about this report visit https://www.researchandmarkets.com/r/gx5pea
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
